New Drug Durvalumab Offers Hope for Bladder Cancer Patients

A trial led by the Institute of Cancer Research shows that durvalumab can spare bladder cancer patients from life-changing surgery and prevent tumour recurrence. Bladder cancer is the ninth most common cancer globally, with aggressive forms typically requiring complete bladder removal.

Read the full story at The Guardian AU→